Dr. Naser Alzein

Dr Naser Alzein is a consultant paediatric haematologist-oncologist currently practising at Mediclinic City Hospital in Dubai. He brings over 30 years of clinical experience, having completed his medical degree at Jordan University of Science and Technology in 1993 and undertaken further training in the United States, where he is double board-certified in paediatrics and paediatric haematology-oncology. Before joining Mediclinic, he served as Chief of the Paediatric Haematology-Oncology Division at Sheikh Khalifa Medical City (SKMC) and held leadership roles including Chairman of Paediatrics at SKMC and medical director of paediatric haematology-oncology at Blank Children's Hospital in Iowa.

Dr Alzein specializes in treating blood cancers and related conditions in children, with a particular focus on acute leukaemia, lymphoma and neuroblastoma. He has extensive experience in bone marrow transplantation and management of benign blood disorders such as haemoglobinopathies. His clinical work is complemented by active research interests in cancer genetics and lymphoma biology, including DNA methylation in B-cell lymphomas. He has been recognized twice with American Society of Oncology (ASCO) Merit Awards for translational medicine research in cancer genetics and won the Lymphoma SPORE Group Grant Award in 2005.

Dr Alzein is known for his teaching contributions, having won the Best Teaching Award from SKMC's Education Department three times. He is a regular speaker at international and regional medical conferences with multiple publications in his field. He is well-suited for families seeking specialist care for childhood blood cancers, leukaemia, lymphoma or children requiring bone marrow transplantation.